MAY 26·SEC EDGARMed
Van Kirk Richard Lee Jr sold $119K of PDEX
Van Kirk Richard Lee Jr (Chief Executive Officer) sold 1,918 shares of PRO DEX INC (PDEX) at $62.22 ($0.12M total) on 2026-05-21 under a Rule 10b5-1 trading plan.
StockNASDAQ · US · USDHealthcare · Medical Instruments & Supplies
$PDEX
PRO DEX INC
Price · $PDEXvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $PDEX in the last 7 days.
Insider · 30dAll trades →
No SEC Form 4 filings for $PDEX in the last 30 days.
See all $PDEX insider activity →Top stories · $PDEXMore →
OCT 30·Zacks Commentary
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Top Estimates
ProDex (PDEX) delivered earnings and revenue surprises of +24.00% and +21.11%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
SEP 4·Zacks Commentary
Pro-Dex, Inc. (PDEX) Lags Q4 Earnings and Revenue Estimates
ProDex (PDEX) delivered earnings and revenue surprises of -23.40% and -2.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PDEX sentiment & insider activity
Recent PDEX coverage spans financial news and insider activity.
What's driving PDEX
Insider selling disclosed for PDEX; likely modest near-term sentiment impact unless follow-on selling accelerates.
Pro-Dex (PDEX) reported Q1 earnings and revenues significantly above estimates, indicating strong operational performance. This positive surprise may lead to short-term stock appreciation, especially among traders focusing on earnings catalysts.
Pro-Dex, Inc. (PDEX) reported earnings and revenue below analyst estimates for Q2 2025, with surprises of -23.40% and -2.27%, respectively. The miss indicates potential short-term weakness.
Pro-Dex reported a 16% revenue increase in Q4 FY2025, indicating growth, but faces margin pressures. The positive revenue trend may support a short-term price increase, but margin concerns could limit upside.
ProDex (PDEX) shows strong growth potential, making it an attractive opportunity for growth-oriented investors.
alphai scores every news story that mentions PDEX with an AI model for sentiment and relevance, and aggregates insider trades from PRO DEX INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $PDEX
Score
Van Kirk Richard Lee Jr sold $119K of PDEX
Van Kirk Richard Lee Jr (Chief Executive Officer) sold 1,918 shares of PRO DEX INC (PDEX) at $62.22 ($0.12M total) on 2026-05-21 under a Rule 10b5-1 trading plan.
1 min read
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Top Estimates
ProDex (PDEX) delivered earnings and revenue surprises of +24.00% and +21.11%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
3 min read
Pro-Dex, Inc. (PDEX) Lags Q4 Earnings and Revenue Estimates
ProDex (PDEX) delivered earnings and revenue surprises of -23.40% and -2.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
3 min read
Pro-Dex Revenue Jumps 16% in Fiscal Q4
Pro-Dex ( NASDAQ:PDEX ) , a developer and manufacturer of powered surgical instruments for medical device OEMs, released its Q4 FY2025 earnings on Sept. 4, 2025. The company reported GAAP revenue of $17.5 million, up from $15.0 million a year earlier, but faces margin pressure as gross margin ...
3 min read
Here is Why Growth Investors Should Buy ProDex (PDEX) Now
ProDex (PDEX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
2 min read
ProDex (PDEX) Upgraded to Buy: Here's Why
ProDex (PDEX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
2 min read
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday - Churchill Downs (NASDAQ:CHDN), DBV Technologies (NASDAQ:DBVT)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Ascendiant Capital raised Pro-Dex, Inc. PDEX price target from $54 to $56.
3 min read
Pro-Dex, Inc. (PDEX) Q3 Earnings Surpass Estimates
ProDex (PDEX) delivered earnings and revenue surprises of 108.51% and 1.62%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
3 min read
ProDex (PDEX) Moves 5.1% Higher: Will This Strength Last?
ProDex (PDEX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
3 min read